Acrivon Therapeutics, Inc. (ACRV)
NASDAQ: ACRV · Real-Time Price · USD
6.50
+0.12 (1.88%)
Nov 20, 2024, 4:00 PM EST - Market closed

Acrivon Therapeutics Stock Forecast

Stock Price Forecast

The 5 analysts with 12-month price forecasts for ACRV stock have an average target of 22.4, with a low estimate of 16 and a high estimate of 30. The average target predicts an increase of 244.62% from the current stock price of 6.50.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $16 $22.4 $22 $30
Change +146.15% +244.62% +238.46% +361.54%

Analyst Ratings

The average analyst rating for ACRV stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Jun '24Jul '24Aug '24Sep '24Oct '24Nov '24
Strong Buy 333332
Buy 443333
Hold 111000
Sell 000000
Strong Sell 000000
Total 887665

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
BMO Capital
BMO Capital
Buy
Maintains
$28$27
Buy Maintains $28$27 +315.38% Nov 14, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$22
Strong Buy Reiterates $22 +238.46% Nov 14, 2024
JMP Securities
JMP Securities
Buy
Reiterates
$17
Buy Reiterates $17 +161.54% Sep 16, 2024
Ladenburg Thalmann
Ladenburg Thalmann
Strong Buy
Upgrades
$16
Strong Buy Upgrades $16 +146.15% Sep 16, 2024
BMO Capital
BMO Capital
Buy
Reiterates
$25$28
Buy Reiterates $25$28 +330.77% Sep 16, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
350.43K
EPS This Year
-2.48
from -2.74
EPS Next Year
-2.76
from -2.48
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
-----350.43K17.30M67.14M
Revenue Growth
------4,837.63%288.00%
EPS
-3.70-9.32-7.56-2.74-2.48-2.76-2.59-2.42
EPS Growth
--------
Forward PE
--------
No. Analysts ----1212106
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025202620272028
High n/a 3.2M 60.2M
Avg n/a 350,431 17.3M
Low n/a n/a n/a

Revenue Growth

Revenue Growth 20242025202620272028
High - -
17,091.7%
Avg - -
4,837.6%
Low - - -

EPS Forecast

EPS 20242025202620272028
High -2.35 -2.10 -1.89
Avg -2.48 -2.76 -2.59
Low -2.87 -3.44 -3.40

EPS Growth

EPS Growth 20242025202620272028
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.